Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Assertio Therapeutics, IncSecurity delisted | AwardD (derivative) | $528.4K | SEC | ||
Assertio Therapeutics, IncSecurity delisted | Exercise | $18.8K | SEC | ||
Assertio Therapeutics, IncSecurity delisted | ExerciseD (derivative) | $18.8K | SEC | ||
Assertio Therapeutics, IncSecurity delisted | Exercise | $34.5K | SEC | ||
Assertio Therapeutics, IncSecurity delisted | ExerciseD (derivative) | $34.5K | SEC | ||
Assertio Therapeutics, IncSecurity delisted | Exercise | $57.2K | SEC | ||
Assertio Therapeutics, IncSecurity delisted | Exercise | $62.4K | SEC | ||
Assertio Therapeutics, IncSecurity delisted | AwardD (derivative) | $152.4K | SEC | ||
Assertio Therapeutics, IncSecurity delisted | AwardD (derivative) | $49.1K | SEC |